iLoF (intelligent Lab on Fiber) is a multi-award-winning deep-tech company accelerating the future of personalised medicine. A spin-out from the University of Oxford and i3S, the firm has developed a disruptive AI-driven platform to revolutionise drug discovery, patient stratification, disease screening and support clinical decisions. Its mission is to slash the cost and time involved in developing new medicines by providing a non-invasive way to stratify patients and to improve patient experience and disease screening, allowing for more informed clinical decisions. By combining photonics and artificial intelligence, iLoF is creating a digital library of biological profiles, enabling pharmaceutical companies to build smarter, more effective clinical trials for complex conditions like Alzheimer’s, and providing primary care facilities with more effective screening tools to cut unnecessary downstream costs.